secwatch.observer — SEC 8-K summary
======================================

Issuer:     Regen BioPharma Inc (RGBP)
CIK:        0001589150
Form:       8-K
Filed at:   2021-11-05T23:59:59+00:00
Accession:  0001607062-21-000487
Event type: debt
Sentiment:  neutral
Materiality: 0.70
Item codes: 8.01
LLM model:  deepseek-v4-flash:cloud@v2

Regen Biopharma reduces convertible note principal by $967,830 via equity and cash
--------------------------------------------------------------------------------

- Satisfied $967,830 of principal and $539,392 in fees/interest through 706M common shares, 23.7M Series A preferred, and $218,529 cash.
- Outstanding convertible note principal fell from $2.36M (June 30, 2021) to $1.40M (November 4, 2021).
- Total debt reduction of approximately $1.51M includes principal, fees, penalties, and accrued interest.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1589150/000160706221000487/0001607062-21-000487-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1589150/000160706221000487/rgbp110521form8k.htm
  HTML page:      https://secwatch.observer/filing/0001607062-21-000487

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer